Skip to main content
. 2008 Jan 23;111(10):4902–4907. doi: 10.1182/blood-2007-10-116327

Table 3.

Predictive model for chemotherapy-associated VTE

Patient characteristic Risk score
Site of cancer
    Very high risk (stomach, pancreas) 2
    High risk (lung, lymphoma, gynecologic, bladder, testicular) 1
Prechemotherapy platelet count 350 × 109/L or more 1
Hemoglobin level less than 100 g/L or use of red cell growth factors 1
Prechemotherapy leukocyte count more than 11 × 109/L 1
BMI 35 kg/m2 or more 1
HHS Vulnerability Disclosure